Research Output per year
Personal profile
Research Biography
Welcome to my homepage. I am currently Beat Cancer Professorial Chair in the College of Medicine and Public Health. I was previously Foundation Director of the Flinders Health and Medical Research Institute and Dean (Research). A former Flinders School of Medicine PhD graduate, I joined Flinders as Director of the Flinders Centre for Innovation in Cancer in 2011 after 16 years with UniSA, stepping down from this role in 2018. At UniSA, I was the inaugural Director of the Sansom Institute (2005-2009) and Associate Head (Research) of the School of Pharmacy and Medical Sciences. An academic pharmacist, I have broad research interests in the pharmacology, pharmaceutical biotechnology and molecular oncology areas. I am a co-inventor of patents relating to cancer chemoprevention (PharmaQest) and the discovery of novel anti-inflammatory compounds. I am a Board Member of Therapeutic Innovation Australia and the Channel 7 Children's Research Foundation. I am a former Vice-President of the International Pharmaceutical Federation (FIP), which represents more than three million pharmacists and Pharmaceutical Scientists globally.
Research Interests
I have broad interests in the pharmacy and pharmaceutical science discipline including drug discovery and development, pharmacogenomics and the quality use of medicines.
Currently funded projects include:
- Precision approaches to anti-cancer medicines (Funding: Cancer Council SA, NHMRC)
- Glucuronidation and cancer (Funding: Cancer Council SA, NHMRC)
- Development of medicines based on traditional indigenous medicine: a collaborative project with the Chuulangun Aboriginal Corporation (Funding: NHMRC, UniSA)
Fingerprint Dive into the research topics where Ross McKinnon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
A literature review of treatment-specific clinical prediction models in patients with breast cancer
Modi, N. D., Sorich, M. J., Rowland, A., Logan, J. M., McKinnon, R. A., Kichenadasse, G., Wiese, M. D. & Hopkins, A. M., Apr 2020, In : Critical Reviews in Oncology/Hematology. 148, 8 p., 102908.Research output: Contribution to journal › Review article
Binding of clozapine to the GABAB receptor: clinical and structural insights
Nair, P. C., McKinnon, R. A., Miners, J. O. & Bastiampillai, T., 1 Sep 2020, In : MOLECULAR PSYCHIATRY. 25, 9, p. 1910-1919 10 p.Research output: Contribution to journal › Article
Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine
Ang, F. L. I., Rowland, A., Modi, N. D., McKinnon, R. A., Sorich, M. J. & Hopkins, A. M., 1 Jan 2020, In : Journal of Cancer. 11, 11, p. 3327-3333 7 p.Research output: Contribution to journal › Article
Open Access
File
Nuances to precision dosing strategies of targeted cancer medicines
Hopkins, A. M., Menz, B. D., Wiese, M. D., Kichenadasse, G., Gurney, H., McKinnon, R. A., Rowland, A. & Sorich, M. J., Aug 2020, In : Pharmacology research & perspectives. 8, 4, 9 p., e00625.Research output: Contribution to journal › Review article
Open Access
File
Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine
Modi, N. D., Sorich, M. J., Rowland, A., McKinnon, R. A., Koczwara, B., Wiese, M. D. & Hopkins, A. M., Apr 2020, In : Clinical Breast Cancer. 20, 2, p. e220-e228Research output: Contribution to journal › Article